BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37353908)

  • 21. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
    Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
    Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.
    Cassar S; Misso ML; Hopkins WG; Shaw CS; Teede HJ; Stepto NK
    Hum Reprod; 2016 Nov; 31(11):2619-2631. PubMed ID: 27907900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
    PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
    Talbott EO; Zborowski J; Rager J; Stragand JR
    Vasc Health Risk Manag; 2008; 4(2):453-62. PubMed ID: 18561521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.
    Dobbie LJ; Pittam B; Zhao SS; Alam U; Hydes TJ; Barber TM; Cuthbertson DJ
    Hum Reprod; 2023 Jun; 38(6):1168-1182. PubMed ID: 37015099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
    Escobar-Morreale HF; Roldán-Martín MB
    Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.
    Glueck CJ; Morrison JA; Wang P
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
    Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
    J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
    Pérez-López FR; López-Baena MT; Pérez-Roncero GR; Chedraui P; Varikasuvu SR; García-Alfaro P
    Gynecol Endocrinol; 2023 Dec; 39(1):2152790. PubMed ID: 36480935
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
    Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
    Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.